Innoviva (NASDAQ: INVA) reported Q3 EPS of $1.08, $0.60 better than the analyst estimate of $0.48. Revenue for the quarter came in at $107.8 million versus the consensus estimate of $92.09 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.